These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21793674)

  • 1. In vivo biodistribution of nanoparticles.
    Almeida JP; Chen AL; Foster A; Drezek R
    Nanomedicine (Lond); 2011 Jul; 6(5):815-35. PubMed ID: 21793674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies.
    Khlebtsov N; Dykman L
    Chem Soc Rev; 2011 Mar; 40(3):1647-71. PubMed ID: 21082078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
    Gupta AK; Gupta M
    Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the Viability of Cells upon Co-Exposure to Gold and Iron Oxide Nanoparticles.
    Zhang Q; Lai W; Yin T; Zhang C; Yue C; Cheng J; Wang K; Yang Y; Cui D; Parak WJ
    Bioconjug Chem; 2018 Jun; 29(6):2120-2125. PubMed ID: 29787236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface charge and dosage dependent potential developmental toxicity and biodistribution of iron oxide nanoparticles in pregnant CD-1 mice.
    Di Bona KR; Xu Y; Ramirez PA; DeLaine J; Parker C; Bao Y; Rasco JF
    Reprod Toxicol; 2014 Dec; 50():36-42. PubMed ID: 25277315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the zeta potential on the sorption and toxicity of iron oxide nanoparticles on S. cerevisiae and E. coli.
    Schwegmann H; Feitz AJ; Frimmel FH
    J Colloid Interface Sci; 2010 Jul; 347(1):43-8. PubMed ID: 20381054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
    Sonavane G; Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(2):274-80. PubMed ID: 18722754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The responses of immune cells to iron oxide nanoparticles.
    Xu Y; Sherwood JA; Lackey KH; Qin Y; Bao Y
    J Appl Toxicol; 2016 Apr; 36(4):543-53. PubMed ID: 26817529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.
    Morais T; Soares ME; Duarte JA; Soares L; Maia S; Gomes P; Pereira E; Fraga S; Carmo H; Bastos Mde L
    Eur J Pharm Biopharm; 2012 Jan; 80(1):185-93. PubMed ID: 21946301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity and genotoxicity of nanosized and microsized titanium dioxide and iron oxide particles in Syrian hamster embryo cells.
    Guichard Y; Schmit J; Darne C; Gaté L; Goutet M; Rousset D; Rastoix O; Wrobel R; Witschger O; Martin A; Fierro V; Binet S
    Ann Occup Hyg; 2012 Jul; 56(5):631-44. PubMed ID: 22449629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes.
    Ying E; Hwang HM
    Sci Total Environ; 2010 Sep; 408(20):4475-81. PubMed ID: 20673962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
    Balogh L; Nigavekar SS; Nair BM; Lesniak W; Zhang C; Sung LY; Kariapper MS; El-Jawahri A; Llanes M; Bolton B; Mamou F; Tan W; Hutson A; Minc L; Khan MK
    Nanomedicine; 2007 Dec; 3(4):281-96. PubMed ID: 17962085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.
    Duan X; Li Y
    Small; 2013 May; 9(9-10):1521-32. PubMed ID: 23019091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are iron oxide nanoparticles safe? Current knowledge and future perspectives.
    Valdiglesias V; Fernández-Bertólez N; Kiliç G; Costa C; Costa S; Fraga S; Bessa MJ; Pásaro E; Teixeira JP; Laffon B
    J Trace Elem Med Biol; 2016 Dec; 38():53-63. PubMed ID: 27056797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface engineering of inorganic nanoparticles for imaging and therapy.
    Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
    Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressing iron oxide nanoparticle toxicity by vascular targeted antioxidant polymer nanoparticles.
    Cochran DB; Wattamwar PP; Wydra R; Hilt JZ; Anderson KW; Eitel RE; Dziubla TD
    Biomaterials; 2013 Dec; 34(37):9615-22. PubMed ID: 24016851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy.
    Zhang XD; Wu D; Shen X; Chen J; Sun YM; Liu PX; Liang XJ
    Biomaterials; 2012 Sep; 33(27):6408-19. PubMed ID: 22681980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response.
    Maiorano G; Sabella S; Sorce B; Brunetti V; Malvindi MA; Cingolani R; Pompa PP
    ACS Nano; 2010 Dec; 4(12):7481-91. PubMed ID: 21082814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.
    He X; Nie H; Wang K; Tan W; Wu X; Zhang P
    Anal Chem; 2008 Dec; 80(24):9597-603. PubMed ID: 19007246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized Fe₃O₄@Au superparamagnetic nanoparticles: in vitro bioactivity.
    Salado J; Insausti M; Lezama L; Gil de Muro I; Moros M; Pelaz B; Grazu V; de la Fuente JM; Rojo T
    Nanotechnology; 2012 Aug; 23(31):315102. PubMed ID: 22802157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.